Pricing Log in Create free account

Universe Pharmaceuticals INC (UPC) vs cbdMD, Inc. (YCBD)

Universe Pharmaceuticals INC and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. Universe Pharmaceuticals INC is the larger, with a market value of $7.0M against $4.4M — 1.6× the size. Universe Pharmaceuticals INC has the higher net margin (−6.42% vs −14.7%) and the higher return on invested capital (0.00% vs −29.8%). Across the 15 metrics below, Universe Pharmaceuticals INC leads on 11 and cbdMD, Inc. on 4.

Valuation

Metric UPC YCBD Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 0.19 2.08
P/B n/m 0.49 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 8.52 n/m 12.22
EV/Sales (0.24) 0.21 2.87
Earnings yield (105.04%) (80.50%) (15.94%)
Free cash flow yield 0.00% (61.46%) 0.00%

Profitability

Metric UPC YCBD Drug Manufacturers Specialty & Generic median
Gross margin 49.77% 57.68% 53.51%
Operating margin 0.00% (13.87%) 0.00%
Net margin (6.42%) (14.71%) (2.45%)
Free cash flow margin 0.00% (11.51%) 0.00%
Return on equity 0.00% (43.01%) (0.80%)
Return on assets 0.00% (26.73%) (1.67%)
Return on invested capital 0.00% (29.78%) 0.00%

Growth

Metric UPC YCBD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 10.01% 5.22%
EPS growth (last fiscal year) 98.71% 92.39% 42.91%
Revenue growth, 5-year CAGR (10.27%) (14.45%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric UPC YCBD Drug Manufacturers Specialty & Generic median
Debt to equity 0.17 0.00 0.04
Current ratio 4.05 2.50 2.41
Net debt to EBITDA 10.15 6.17 1.01

Dividend

Metric UPC YCBD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric UPC YCBD Drug Manufacturers Specialty & Generic median
Market cap 7.04m 4.35m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack